Sign In
NewsRadar

REVOTAR Biopharmaceuticals

Revotar is a biopharmaceutical company developing small molecule anti-inflammatory drugs for indications such as asthma, psoriasis, ALI/ARDS and COPD. The company was endowed from the start with the asset bimosiamose, an innovative proprietary drug product (selectin antagonist) for the therapy of a variety of inflammatory disorders. Its advanced drug candidate bimosiamose has passed three Phase II a (proof of concept) clinical trials in Asthma and Psoriasis.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
Neuendorfstrasse 24a
Hennigsdorf 16761
Germany
+4933022025010
+49330220250 30
http://www.revotar.de
Martin Pöhlchen
+49 (3302) 20250 10

Company Facts
Founded:Dec 2000
Founders:
CEO:Martin Pöhlchen
CTO or technical lead:
CFO or finance director:
Head of Sales:
Head of Marketing:

Stage:Growth
Category:Biotechnology & Healthcare
Sector:Biopharmaceuticals
Employees:
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

Key Customers

Key Business Partners

Key Competitors

Capital Raised
DateSizeInvestors
To view this information you must be signed in and subscribed to the online dataservice, sign in here.

To read more about the Online data service click here

Public Offerings
DateTypeExchange
No public offerings


Data


27,717
Tech investments
From our Online Data Service
17,879
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Dec 21€50.0MKnowledge management
Dec 20€16.0MSemiconductors
Dec 17€18.0MOther Computers & Electronics
Dec 17€5.2MBiotechnology
Dec 17€17.0MBusiness applications
Dec 15€17.0ME-Commerce
Dec 4€3.3MNanotechnology

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Sep 30
TetaVi
tetavi raises $6 million to help more companies bring 3d holograms ...

May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Mar 31
CompPair
the fit allocates chf 100'000 to comppair technologies

Jan 29
Yumpingo
yumpingo raises $10m to transform guest experiences in restaurants





About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.